Experimental mRNA vaccine cuts risk melanoma returns by 42%
General Idaho
Archived
•
October 22, 2026
•
By Meg Tirrell, CNN (CNN) — When the news arrived in August that what could be the first personalized mRNA cancer vaccine had succeeded in a late-stage clinical trial in melanoma, oncologists and the public alike were exhilarated. And that was before its makers had even disclosed just how well the therapy worked. Now they
Source: Local News 8 (KIFI) | https://localnews8.com/feed/ - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!


